Halina Snowball, MD
Physical Medicine & Rehabilitation · Stamford, CTNPI 1609848480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 34.1% of the total. Reporting peaked in 2023 at $395 and has fallen 76.4% since, to $93 in 2025.
Across 65 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$447
- Ferring Pharmaceuticals Inc.$435
- Merz North America, Inc.$98
- Galderma Laboratories, L.p.$77
- Pfizer$56
- Johnson & Johnson$53
- plus $144 from 5 others
What the payments were for
- Food & beverage$1,310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $447 |
| Ferring Pharmaceuticals Inc. | 25 | $435 |
| Merz North America, Inc. | 1 | $98 |
| Galderma Laboratories, L.p. | 4 | $77 |
| Pfizer | 3 | $56 |
| Johnson & Johnson | 2 | $53 |
| Bioventus LLC | 2 | $44 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Fidia Pharma USA Inc. | 1 | $27 |
| Amgen | 1 | $22 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$1,310 in reported general payments places this provider in the 80th percentile of 107 physical medicine & rehabilitation providers in Connecticut.
See all physical medicine & rehabilitation providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 113 | $2,847 |
| Duloxetine Hcl | 28 | $2,084 |
| Diclofenac Sodium | 14 | $892 |
| Tizanidine Hcl | 81 | $853 |
| Doxepin Hcl | 16 | $687 |
| Gabapentin | 40 | $432 |
| Tramadol Hcl | 71 | $333 |
| Cyclobenzaprine Hcl | 19 | $134 |
| Meloxicam | 58 | $113 |
| Ondansetron Hcl | 11 | $72 |
| Alprazolam | 11 | $55 |
| Lorazepam | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Stamford
- Peter MoleyStamford$5K
- Stephen MassimiStamford$123
- Charles OdonkorOld Saybrook$81K
- Bridget WalkerHartford$41K
- Michael BrennanFairfield$19K
- Robert KrugHartford$14K
- Michael WongMilford$12K
- Daniel KlineBranford$10K
- Matthew RaymondSouthington$4K
- Mitchell PrywesDanbury$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.